Search Orphan Drug Designations and Approvals
-
Generic Name: | trabectedin |
---|---|
Date Designated: | 03/29/2005 |
Orphan Designation: | Treatment of patients with ovarian cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Janssen Research & Development, LLC 920 Route 202 South Raritan, New Jersey 08869 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-